Germany's telecoms regulator says Huawei can stay in the 5G network race, the European Central Bank faces stimulus pressure over a falling inflation outlook and the FT reports that Purdue Pharma, the makers of Oxycontin, tried to buy Reckitt Benckiser's addiction treatment business. Plus, the FT's Camilla Hodgson sets up the $30bn legal battle between Apple and Qualcomm that will play out in a San Diego court on Monday.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av FT News Briefing
Visa alla avsnitt av FT News BriefingFT News Briefing med Financial Times finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
